|
BRWD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.961700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.26449999998868E-06 |
| Normal-vs-Stage2 |
2.776300E-02 |
| Normal-vs-Stage3 |
2.304400E-01 |
| Normal-vs-Stage4 |
8.763600E-01 |
| Stage1-vs-Stage2 |
5.773800E-01 |
| Stage1-vs-Stage3 |
8.879300E-03 |
| Stage1-vs-Stage4 |
2.800300E-04 |
| Stage2-vs-Stage3 |
1.946550E-01 |
| Stage2-vs-Stage4 |
4.088100E-02 |
| Stage3-vs-Stage4 |
3.754200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.950640E-04 |
| Normal-vs-AfricanAmerican |
8.214200E-01 |
| Normal-vs-Asian |
1.379240E-01 |
| Caucasian-vs-AfricanAmerican |
1.535960E-02 |
| Caucasian-vs-Asian |
1.829980E-01 |
| AfricanAmerican-vs-Asian |
2.708000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.922800E-03 |
| Normal-vs-Female |
1.937020E-03 |
| Male-vs-Female |
7.026400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.179800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.8773000000012E-05 |
| Normal-vs-Age(61-80Yrs) |
1.825690E-02 |
| Normal-vs-Age(81-100Yrs) |
7.637200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.547200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.272000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.627800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.247800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.562840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.831000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.494000E-02 |
| Normal-vs-Grade 2 |
1.60708999999981E-05 |
| Normal-vs-Grade 3 |
2.808300E-02 |
| Normal-vs-Grade 4 |
6.259400E-01 |
| Grade 1-vs-Grade 2 |
1.443370E-01 |
| Grade 1-vs-Grade 3 |
1.549940E-02 |
| Grade 1-vs-Grade 4 |
1.914180E-02 |
| Grade 2-vs-Grade 3 |
2.079800E-02 |
| Grade 2-vs-Grade 4 |
6.14439999999661E-05 |
| Grade 3-vs-Grade 4 |
3.281900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.80720000367785E-08 |
| Normal-vs-ccB subtype |
3.043700E-02 |
| ccA subtype-vs-ccB subtype |
1.601160E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.403600E-03 |
| Normal-vs-N1 |
9.123400E-01 |
| N0-vs-N1 |
2.845800E-01 |
|
|
